Liver Injury Induced by the Interaction Between Fluoxetine and Celecoxib: A Case Report and the Literature Review

被引:0
作者
Zhang, Hong-Mei [1 ]
Liu, Guang-Chen [2 ]
He, Yang-Fang [3 ]
Zhou, Wei [1 ]
Hou, Ji-Qiu [4 ]
机构
[1] First Hosp Jilin Univ, Dept Pharm, 71 Xinmin Ave, Changchun, Jilin, Peoples R China
[2] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp 2, Dept Orthoped, Wuxi, Jiangsu, Peoples R China
[3] Second Hosp Jilin Univ, Dept Endocrinol & Metab, Changchun, Jilin, Peoples R China
[4] Second Hosp Jilin Univ, Dept Pharm, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China
关键词
Adverse Drug Reactions; Alanine Transaminase; Aspartate Aminotransferases; CYP2C19; Protein; Celecoxib; China; Fluoxetine; Human; Injury; Liver; GENETIC POLYMORPHISMS; CHOLESTATIC HEPATITIS; DRUG-METABOLISM; IN-VITRO; PHARMACOKINETICS; PATIENT; CYP2D6;
D O I
10.5812/ircmj.93271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Fluoxetine is used commonly as an antidepressant and celecoxib is widely used for pain relief and reducing inflammation in various chronic conditions. Both of them can cause liver injury, but it is a rare adverse reaction of their interactions. Here we report a case of liver injury possibly induced by fluoxetine and celecoxib in a female patient. Case Presentation: A 55-year-old woman who was given fluoxetine for three months and celecoxib for seven days was transferred to the Department of Emergency, the first affiliated hospital of Jilin University, Changchun, China, on March 2019, with icterus on the skin, dark brown urine and pain in the upper abdomen. Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) levels were elevated. According to follow-up examination, liver injury and cholecystitis were diagnosed. After discontinuing the two drugs and starting symptomatic treatment, her ALT and AST levels returned to normal. Conclusions: The mechanism of liver injury induced by fluoxetine and celecoxib remains unclear. Inhibitors and substrates of CYP2D6, CYP2C9, CYP3A4, and CYP2C19 might participate in this situation. The interaction between fluoxetine and celecoxib, as well as other inhibitors and substrates with similar metabolic pathways, are noteworthy.
引用
收藏
页数:5
相关论文
共 26 条
[1]   Methods for causality assessment of adverse drug reactions - A systematic review [J].
Agbabiaka, Taofikat B. ;
Savovic, Jelena ;
Ernst, Edzard .
DRUG SAFETY, 2008, 31 (01) :21-37
[2]   Fluoxetine-induced Stevens-Johnson syndrome and liver injury [J].
Agrawal, Rohit ;
Almoghrabi, Anas ;
Attar, Bashar M. ;
Gandhi, Seema .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (01) :115-118
[3]   Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis [J].
Alegria, P ;
Lebre, L ;
Chagas, C .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (01) :75-75
[4]   Fast evaluation of enantioselective drug metabolism by electrophoretically mediated microanalysis: Application to fluoxetine metabolism by CYP2D6 [J].
Asensi-Bernardi, Lucia ;
Martin-Biosca, Yolanda ;
Escuder-Gilabert, Laura ;
Sagrado, Salvador ;
Jose Medina-Hernandez, Maria .
ELECTROPHORESIS, 2013, 34 (22-23) :3214-3220
[5]   Acute hepatitis due to fluoxetine therapy [J].
Cai, Q ;
Benson, MA ;
Talbot, TJ ;
Devadas, G ;
Swanson, HJ ;
Olson, JL ;
Kirchner, JP .
MAYO CLINIC PROCEEDINGS, 1999, 74 (07) :692-694
[6]   Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation [J].
El Hajj, Ihab I. ;
Malik, Shahid M. ;
Alwakeel, Hany R. ;
Shaikh, Obaid S. ;
Sasatomi, Eizaburo ;
Kandil, Hossam M. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (31) :3937-3939
[7]   Celecoxib-induced cholestatic hepatitis [J].
Galan, MV ;
Gordon, SC ;
Silverman, AL .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (03) :254-254
[8]   Acute cholestatic hepatitis associated with celecoxib [J].
Grieco, A ;
Miele, L ;
Giorgi, A ;
Civello, IM ;
Gasbarrini, G .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (12) :1887-1889
[9]  
Johnston DE, 1997, AM J GASTROENTEROL, V92, P1225
[10]   Fatal cholestatic hepatitis after a single dose of celecoxib [J].
Larrey, E. ;
Patouraux, S. ;
Spreux, A. ;
Canivet, C. M. ;
Piche, T. ;
Tran, A. ;
Anty, R. .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (05) :E82-E85